⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17975864 | 0.63 | — | — | |
| SCHEMBL7157029 | 0.62 | — | — | |
| SCHEMBL467759 | 0.62 | — | — | |
| SCHEMBL907971 | 0.62 | — | — | |
| SCHEMBL907622 | 0.62 | — | — | |
| SCHEMBL544750 | 0.60 | LMNA (0.35) | — | |
| SCHEMBL28310143 | 0.60 | LMNA (0.35) | — | |
| SCHEMBL818625 | 0.60 | — | — | |
| SCHEMBL1990974 | 0.58 | — | — | |
| SCHEMBL7521555 | 0.58 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1999167-A2 | ZIEGLER-NATTA CATALYST WITH IN SITU-GENERATED DONOR | Novolen Technology Holdings, C.V. (NL) | 2008-12-10 | — | — | EP | disclosed |
| WO-2007106348-A2 | ZIEGLER-NATTA CATALYST WITH IN SITU-GENERATED DONOR | NOVOLEN TECHNOLOGY HOLDINGS C.V. (NL) | 2007-09-20 | — | — | WO | disclosed |
| US-20070213204-A1 | Ziegler-Natta catalyst with in situ-generated donor | NOVOLEN TECHNOLOGY HOLDINGS C.V. | 2007-09-13 | — | — | US | disclosed |
| EP-0858462-B1 | SUPPORTABLE BISCYCLOPENTADIENYL METAL COMPLEXES | DOW CHEMICAL CO (US) | 2002-07-03 | — | — | EP | disclosed |
| US-5854362-A | Supported biscyclopentadienyl metal complexes | THE DOW CHEMICAL COMPANY (US) | 1998-12-29 | — | — | US | disclosed |